Summary
A melanoma-associated membrane antigen and a fetal brain antigen were identified on the surface of a human melanoma cell line by indirect membrane immunofluorescence techniques. The target melanoma cells were grown in gamma globulin-depleted human serum. Sera from melanoma patients were used as the source of antimelanoma antibodies. To remove alloantibodies, the allogeneic sera were preabsorbed with cultured lymphoblastoid cells derived from the peripheral lymphocytes of the donor of the target cell line. To further define the antigen responsible for antibody activity, sequential absorption tests were performed with fetal brain cells, cultured sarcomas, and breast carcinomas. Some antibody activity was removed by fetal brain tissues. Further absorption with fetal brain or the cultured sarcoma or breast carcinoma did not remove additional activity. However, antibody activity was completely removed by either cultured or biopsy-derived melanoma cells. A serum autochthonous to the target cell line was also tested. The antibody titer of the serum was completely removed by absorption with either autochthonous biopsied tumor or an allogeneic melanoma cell line, but not with the normal tissues. Thus it appeared that sera from melanoma patients contained antibody to both a melanoma-associated membrane antigen and a fetal brain antigen.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Carey, T. E., Takahashi, T., Resnick, L. A., Oettgen, H. F., Old, L. J.: Mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cells. Proc. Natl. Acad. Sci. USA 73, 3278 (1976).
Cochran, A. J., Mackie, R. M., Thomas, C. E., Grant, R. M., Cameron-Mowat, D. E., Spilg, W. G. S.: Cellular immunity to breast carcinoma and malignant melanoma. Br. J. Cancer 28 (SI), 77 (1973).
Currie, G. A., Lejeune, F., Fairley, G. H.: Immunization with irradiated tumor cells and specific lymphocyte cytotoxicity in malignant melanoma. Br. Med. J. 1971 II, 305.
Fossati, G., Colnagli, M. I., Della Porta, G., Cascinelli, N., Veronesi, U.: Cellular and humoral immunity against human malignant melanoma. Int. J. Cancer 8, 344 (1971).
Hollinshead, A. C.: Analysis of soluble melanoma cell membrane antigens in metastatic cells of various organs and further studies of antigens present in primary melanoma. Cancer 36, 1282 (1975).
Hollinshead, A. C., Herberman, R., Jaffurs, W., Alpert, L., Minton, J., Harris, J.: Soluble membrane antigens of human malignant melanoma cells. Cancer 34, 1235 (1974).
Irie, K., Irie, R. F., Morton, D. L.: Evidence for in vivo reaction of antibody and complement to surface antigens of human cancer cells. Science 186, 434 (1974).
Irie, R. F., Irie, K., Morton, D. L.: Natural antibody in human serum to a neoantigen in human cultured cells grown in fetal bovine serum. J. Natl. Cancer Inst. 52, 1051 (1974).
Irie, R. F., Irie, K., Morton, D. L.: A membrane antigen common to human cancer and fetal brain tissues. Cancer Res. 36, 3510 (1976).
Leong, S. P. L., Sutherland, C. M., Krementz, E. T.: Immunofluorescent detection of common melanoma membrane antigens by sera of melanoma patients immunized against autologous or allogeneic cultured melanoma cells. Cancer Res. 37, 4035 (1977).
Lewis, M. G., Ikonopisov, R. L., Nairn, R. C., Phillips, T. M., Jairley, J. H., Bodenham, D. C., Alexander, P.: Tumor-specific antibodies in human malignant melanoma and their relationship to the extent of the disease. Br. Med. J. 1969 III, 547.
Metzgar, R. S., Bergoc, P. M., Moreno, M. A., Seigler, H. F.: Melanoma antibodies produced in monkeys by immunization with human melanoma cell lines. J. Natl. Cancer Inst. 50, 1065 (1973).
Möller, G.: Demonstration of mouse isoantigens at the cellular level by the fluorescent antibody technique. J. Exp. Med. 114, 415 (1961).
Morton, D. L., Malmgren, R. A., Holmes, E. C., Ketcham, A. S.: Demonstration of antibodies against human malignant melanoma by immunofluorescence. Surgery 64, 233 (1968).
Nairn, R. C., Nind, A. P. P., Guli, E. P. G., Davis, D. J.: Antitumor immunoreactivity in patients with malignant melanoma. Med. J. Aust. 1, 397 (1972).
Pellegrino, M. A., Ferrone, S., Reisfeld, R. F., Irie, R. F., Golub, S. H.: Expression of histocompatibility (HLA) antigens on tumor cells and normal cells from patients with melanoma. Cancer 40, 36 (1977).
Romsdahl, M. M., Cox, I. S.: Human malignant melanoma antibodies demonstrated by immunofluorescence. Arch. Surg. 100, 491 (1970).
Seibert, E., Sorg, C., Macher, E.: Membrane-associated antigens of human malignant melanoma: III. Specificity of human sera reacting with cultured melanoma cells. Int. J. Cancer 19, 172 (1977).
Shiku, H., Takahashi, T., Oettgen, H. R., Old, L. J.: Cell surface antigens of human malignant melanoma. II. Serological typing with immune adherence assays and definition of two new surface antigens. J. Exp. Med. 144, 873 (1976).
Stuhlmiller, G. M., Seigler, H. F.: Enzymatic susceptibility and spontaneous release of human melanoma tumor-associated antigens. J. Natl. Cancer Inst. 58, 215 (1977).
The, T. H., Huiges, H. A., Schradffordt Koops, H., Lamberts, H. B., Nieweg, H. O.: Surface antigens on cultured malignant melanoma cells as detected by a membrane immunofluorescence method with human sera: Lack of tumor-specific reactions on melanoma cells. Ann. N.Y. Acad. Sci. 254, 528 (1975).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Irie, K., Irie, R.F. & Morton, D.L. Humoral immune response to melanoma-associated membrane antigen and fetal brain antigen demonstrated by indirect membrane immunofluorescence. I. Cancer Immunol Immunother 6, 33–39 (1979). https://doi.org/10.1007/BF00206014
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00206014